Neutrophil store-operated Ca2+ entry: A correctable biomarker of cystic fibrosis lung disease progression
Journal of Cystic Fibrosis · 2025
DOI: 10.1016/j.jcf.2025.08.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2025. Verfasst von Joe A Wrennall und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, NC, 27599. Hauptthemen laut MEDLINE: Neutrophils, Cystic Fibrosis, Calcium, ORAI1 Protein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
RATIONALE: People with cystic fibrosis (pwCF) exhibit chronic and hyperactive neutrophilia which results in a progressive loss of lung function. CF neutrophils have elevated store operated Ca2+ entry (SOCE) relative to healthy non-CF neutrophils, which contributes to persistent neutrophilia. The vast majority of pwCF now take CFTR modulators such as elexacaftor/tezacaftor/ivacaftor (ETI), which effectively increase CFTR function in multiple organs including the lung. However, ETI's impact on neutrophils is poorly understood. Orai1 is a plasma membrane Ca2+ channel that contributes to SOCE. We have developed a novel peptide (ELD607) that specifically inhibits Orai1, which we evaluated in CF neutrophils. OBJECTIVES: To characterize Orai1/SOCE in neutrophils from pwCF taking ETI, and to evaluate the impact of SOCE inhibition by ELD607 on pwCF neutrophil Ca2+ signaling/function. METHODS: Peripheral blood neutrophils were isolated by negative selection. SOCE was characterized using fluorescent approaches. Protein expression was characterized by proteomics and confocal microscopy. Neutrophil degranulation was measured using a multiplex assay. MEASUREMENTS AND MAIN RESULTS: Proteomic analysis revealed major global differences between non-CF and pwCF neutrophils, despite use of ETI. Several proteins involved in SOCE, including Orai1, were significantly elevated in pwCF neutrophils. ELD607 dose-dependently inhibited SOCE, leading to reduced neutrophil degranulation. Ca2+ homeostasis was significantly elevated in pwCF compared to non-CF neutrophils. ELD607-sensitive SOCE inversely correlated with lung function (FEV1pp). CONCLUSIONS: Our findings highlight SOCE as a novel biomarker of CF lung disease. ELD607 can be used to reduce SOCE and subsequent degranulation in CF neutrophils. We therefore hypothesize that ELD607 may be of benefit in the management of inflammation in pwCF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Physiology, University of North Carolina at Chapel Hill, NC, 27599.
- Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA.
- Division of Genetic, Environmental and Inhalational Disease, Department of Internal Medicine, Kansas University Medical Center, Kansas City, KS, 66103, USA. Electronic address: rtarran@kumc.edu.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- National Heart Lung and Blood Institute Division of Intramural Research
- National Institutes of Health
- Cystic Fibrosis Foundation
- National Heart Lung and Blood Institute
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
Zitieren
APA
Wrennall, J. A., Biggart, M. G., Bengtson, C. D., Sassano, M. F., & Tarran, R. (2025). Neutrophil store-operated Ca2+ entry: A correctable biomarker of cystic fibrosis lung disease progression. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.08.014
Vancouver
Wrennall JA, Biggart MG, Bengtson CD, Sassano MF, Tarran R. Neutrophil store-operated Ca2+ entry: A correctable biomarker of cystic fibrosis lung disease progression. Journal of Cystic Fibrosis. 2025. doi:10.1016/j.jcf.2025.08.014
BibTeX
@article{Wrennall2025,
author = {Wrennall, Joe A and Biggart, Matthew Gs and Bengtson, Charles D and Sassano, M Flori and Tarran, Robert},
title = {Neutrophil store-operated Ca2+ entry: A correctable biomarker of cystic fibrosis lung disease progression},
journal = {Journal of Cystic Fibrosis},
year = {2025},
doi = {10.1016/j.jcf.2025.08.014}
}
EUVIMED